Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Analgesia in Children After Ravitch Procedure and Thoracotomy
NCT03444636Phase 4
Key facts
- Status
- Completed
- Start
- Mar 2015
- Primary completion
- Mar 2017
- Countries
- 1
- Modality
- Orthosteric Ligands
- Drugs
- ropivacaine
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms). Primary endpoints: Pain intensity scores at rest, Pain intensity scores during deep breathing and 2 more. Started Mar 2015; status: completed.
02
Design
2 arms- Study design
- Randomized
Ropivacaine/Fentanyl
Ropivacaine 0.2% + Fentanyl 5 µg/ml continuous epidural infusion.
Bupivacaine/Fentanyl
Bupivacaine 0.125% + Fentanyl 5 µg/ml continuous epidural infusion.
03
Who it enrols
Patients aged 6-18 years undergoing elective thoracic surgery (thoracotomy or Ravitch procedure) with continuous thoracic epidural analgesia. Excludes patients with ASA > III, chronic pain, preoperative opioid use, oncological treatment, impaired verbal communication, or early catheter removal.
04
Endpoints
Primary
Pain intensity scores at rest
Pain intensity scores during deep breathing
Pain intensity scores during coughing
Side Effect Occurrence
Secondary
Total fentanyl consumption
The number of doses of metamizol as a 'rescue drug'
The number of nursing interventions undertaken to relive pain > 2/10 pts
Patient satisfaction
Beyond the preview
Go deeper on NCT03444636.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03444636.